Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$112,515,541
+$25,085,214 QoQ
Shares Held
447,129
+11.2% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
2.13%
of 13F equity value
Holder Rank
#237
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL ADVISORS INC/OK holds $173,896,300 across 10 Drug Manufacturers - General names. ABBV ranks #1 (64.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
447,129 | $112,515,541 | |
| 2 | PFE |
Pfizer Inc
|
1,770,761 | $42,639,924 | |
| 3 | LLY |
ELI LILLY & Co
|
6,287 | $7,540,817 | |
| 4 | JNJ |
Johnson & Johnson
|
22,507 | $5,716,102 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,641 | $1,419,814 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,821 | $1,261,998 | |
| 7 | NVO |
Novo Nordisk A S
|
25,516 | $1,223,237 | |
| 8 | AMGN |
Amgen Inc
|
2,255 | $816,580 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,515,541 | 447,129 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $87,430,327 | 401,997 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $89,241,339 | 390,570 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $88,366,777 | 381,648 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $64,428,702 | 347,100 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $72,662,374 | 346,804 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $59,531,454 | 335,011 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $65,147,072 | 329,892 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $60,476,751 | 352,593 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $62,699,579 | 344,314 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $63,311,908 | 408,543 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $56,291,763 | 377,645 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $49,812,510 | 369,721 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $55,436,057 | 347,845 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $55,498,328 | 343,409 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $45,978,332 | 342,585 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $51,071,967 | 333,455 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $53,133,659 | 327,763 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $43,782,131 | 323,354 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $34,831,330 | 322,901 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $36,249,241 | 321,815 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $34,017,009 | 314,332 | Shares | Sole | 2021-05-25 | |
| 2020-12-31 | $32,617,210 | 304,407 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $25,865,502 | 295,302 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $28,556,634 | 290,860 | Shares | Sole | 2020-09-02 | |
| 2020-03-31 | $21,748,359 | 285,449 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||